41 matches for your search in the start-up spotlight
rss
Isomorphic Labs announces $600m external investment round
03-Apr-2025
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing investor, Alphabet. Isomorphic Labs was founded ...
"Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories
02-Apr-2025
From blood analyses to cancer diagnostics - the examination and analysis of biological molecules, tissue, cells and genetic engineering, the development of vaccines and medical tests are carried out in wet laboratories. Thanks to the standardisation of equipment and work processes, solutions are ...
"The Polybot project leverages recent breakthroughs in machine learning to make polyculture farming economically viable"
10-Mar-2025
The harvesting robot project Polybot is supported by the Federal Agency for Breakthrough Innovation (Deutsche Agentur für Sprunginnovation: SPRIND) with a seven-month validation grant of approximately 220,000 euros. This funding will help the team to prepare the transition from scientific ...
In 2024, 37 new spin-offs were founded at ETH Zurich, a large proportion of them in the fields of AI and biotechnology.
04-Feb-2025
With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research. Start-ups in the fields of artificial intelligence and biotechnology were particularly well represented. Artificial Intelligence and machine learning led the list with ten ...
Investments will support new product offerings, US expansion, and development of pathology foundation models
05-Nov-2024
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...
Antiverse raises £3.5M
21-Oct-2024
Antiverse, a techbio company designing antibodies for challenging targets, announced it has added £3.5M ($4.6M) to its seed funding. The investment will facilitate the Company’s growth, including appointments to strengthen the team and continued development of its antibody design programmes, many ...
Insilico Medicine and Inimmune achieved collaboration to revolutionize immunotherapy with AI-driven drug discovery
12-Sep-2024
Insilico Medicine announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation ...
Startup will use funds to fine-tune their AI models for diagnostics and biomarker discovery
05-Sep-2024
The Berlin-based startup Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité - Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, ...
Berlin-based Climate Tech startup Seqana raises €2.1M Seed round
03-Jun-2024
Seqana has secured €2.1M from German seed investor HTGF and carbon removal firm Counteract to refine its soil carbon measurement algorithm. Food and beverage companies are embracing carbon farming practices utilizing soil-based carbon storage to align with current regulations, meet consumer ...
Smart Reporting successfully closes financing round for 23 million euros
24-Apr-2024
Smart Reporting has successfully completed a financing round of 23 million euros. TVM Capital Life Science (lead investor) and Bayern Kapital are newly on board in the Series C funding, while the existing investors are also participating in the financing round. The capital raised will primarily ...
